Citigroup

Citigroup slashed its Coinbase price target 41% to $235 on July 24, citing expected spot trading volume declines to two-year lows, yet maintained its buy rating, a contradiction that signals institutional uncertainty heading into Q2 earnings. The divergence between buy ratings and compressed price targets across Wall Street suggests the market is pricing in near-term weakness while betting on regulatory tailwinds from pending U.S. crypto legislation to drive longer-term recovery.

• Citi cut Coinbase target from $400 to $235 on July 24, a 41% reduction ahead of earnings.
• Q2 revenue expected near $1.3 billion, down 13% year-over-year, with transaction revenue forecast at $640 million.
• Multiple analysts trimmed targets simultaneously as COIN stock fell 29% year-to-date despite 5% monthly gains.

• 41% Reduction in Citi’s price target from prior $400 estimate.
• $1.3B Expected Q2 revenue, down 13 percent versus year-ago quarter.
• $152B Estimated trading volume handled, below consensus view of $178 billion.

Coinbase headed into second-quarter earnings on July 31 facing a wall of caution from the institutional research community that underscores a fundamental tension in the stock’s valuation: near-term operational headwinds colliding with longer-term legislative optimism.

Citigroup’s move to slash its price target from $400 to $235 while retaining a buy rating crystallizes the split-decision positioning that now dominates the Street. The 41% cut arrived just days before earnings, signaling that even bullish analysts no longer expect near-term upside while maintaining conviction in the company’s strategic positioning.

Citi Keeps Buy Rating While Slashing Target 41% on Volume Collapse

Citi analyst Peter Christiansen’s decision to maintain a buy rating despite cutting his 12-month price target by $165 per share reflects a specific, measurable concern: spot trading volumes at Coinbase are expected to decline to two-year lows in the second quarter.

This forecast of anemic trading activity directly pressures transaction revenue, the largest and most volatile component of Coinbase’s earnings. For institutional investors accustomed to sell-side consensus, the gap between buy ratings and subdued price targets signals that the downside case is now more credible than the Street’s baseline.

Coinbase had already missed revenue estimates in the prior quarter, and the stock had fallen 29% since the start of 2026 before Citi’s cut. That backdrop meant the market was not surprised by tighter guidance, but the magnitude of Citi’s reduction, larger than most expected, forced a reappraisal across multiple desks.

Clear Street trimmed its target to $225, close to Citi’s new level, while Rosenblatt Securities held at $240, suggesting convergence around a $225, $240 range that is roughly 40% below Citi’s previous anchor. The synchronization of these cuts across major institutions implies that the old $400 target was no longer defensible under current trading conditions.

Christiansen’s reasoning was direct: the firm expects Q2 to mark a cyclical trough for transaction volumes. This is not a call on Coinbase’s market share or long-term moat, but rather a diagnosis of industry-wide crypto trading weakness.

The implication for institutional capital is that current quarter results are likely to disappoint on the revenue line, making the earnings date a potential sell-the-news event unless management offers concrete visibility on a rebound or announces cost discipline.

Wall Street Expects Revenue Down 13% as Transaction Volumes Compress

Consensus estimates for Q2 revenue cluster around $1.3 billion, representing a 13% decline from the same quarter in 2025 and falling short of the $1.41 billion Coinbase posted in Q1 2026. The pressure comes almost entirely from transaction revenue, which analysts forecast at approximately $640 million, a direct function of lower spot trading volumes.

Barclays research suggests Coinbase handled roughly $152 billion in quarterly volume, well below the Street’s consensus estimate of $178 billion, a gap that reflects the severity of the industry’s current trading drought.

The transaction revenue shortfall is the core story because it is the least predictable and most pro-cyclical part of Coinbase’s business model. However, the company’s subscription and services business, which includes USDC interest income and staking revenue, provides a cushion.

This steadier revenue stream has become increasingly valuable as spot trading has weakened, and it explains why Coinbase stock has managed to climb 5% month-on-month despite the year-to-date 29% decline. Institutional investors are factoring in this shift toward recurring, lower-volatility revenue as a reason to retain long exposure despite compressed near-term estimates.

The earnings print will confirm or refute these volume and revenue assumptions, but analysts have already taken a conservative stance. Management’s forward guidance on trading conditions and any commentary on cost structure will likely determine whether the sell-off continues or whether the stock finds support at current levels.

The Street’s consensus has essentially priced in a weak quarter, which raises the bar for an upside surprise.

Pending U.S. Crypto Legislation Anchors Longer-Term Bull Case Despite Earnings Weakness

Beneath the near-term earnings gloom sits a regulatory catalyst that has already begun to lift Coinbase stock from its lows: the CLARITY Act, a federal market-structure bill designed to give crypto exchanges clear regulatory authority and guardrails.

The legislation would establish an explicit federal framework for spot trading, clearing, and custody, removing legal ambiguity that has deterred institutional participation.

Coinbase and other major platforms have lobbied heavily for this bill, and recent signals suggest it is nearing passage, which has already triggered a rally in COIN stock ahead of what most analysts expect to be a disappointing earnings report.

The disconnect between Q2 fundamentals and the rally is not a coincidence. Institutional investors are explicitly trading through the current earnings cycle in anticipation of regulatory clarity that could unlock a new tier of institutional capital, new product listings, and margin products.

A passed CLARITY Act would represent a structural shift in the competitive and capital-flows backdrop for Coinbase, justifying current or higher valuations on a forward basis even if Q2 results are weak.

This forward-looking positioning explains why analysts maintain buy ratings despite slashed price targets, the targets are largely backward-looking cash flow estimates, while the ratings reflect a belief in the longer-term benefit of regulatory clarity.

The timing of this earnings cycle against pending legislation creates a specific institutional quandary: sell into near-term weakness and miss a potential regulatory-driven rally, or hold through a disappointing quarter betting on legislative passage.

The positioning data, including put-call ratios and options flow, shows institutional investors are split on this decision, with some de-risking ahead of earnings and others building or maintaining long positions ahead of a potential CLARITY Act passage.

The coming weeks will test whether the CLARITY Act passes and whether Coinbase management provides any near-term visibility on a rebound in spot volumes. A weak Q2 earnings miss combined with guidance that Q3 remains subdued could pressure the stock past the $235 Citi target, even if regulatory optimism remains intact. Conversely, if management signals that transaction volumes have stabilized or begun to recover, and if the CLARITY Act shows legislative momentum, the stock could reclaim the $250, $300 range and vindicate Citi’s buy rating despite the slashed target. The next major catalyst is Coinbase’s earnings release and management commentary on industry trading conditions and the regulatory outlook.